24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
09/12/2014
ADAM involved in the project of shared DC between Malaysia and Catalonia
02/12/2014
ESADE, 4th best business school in Europe
25/11/2014
Nanoparticle technology triples the production of biogas
13/11/2014
A little piece of SENER on comet 67P
05/11/2014
New catalysts investigated with the ALBA Synchrotron
04/11/2014
SENER hosts a meeting with ESA, NASA and ROSKOSMOS in its offices in BSP